New aims and next steps for adult ALL induction therapy
CAR T-cells directed against BCMA in MM
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients
Michael J. Mauro
CAR T-cells: an advancement in treating MM?
Comparing ibrutinib efficacy and toxicity levels by age for patients with CLL/SLL